Earlier this month, the largest settlement yet levied against a pharmaceutical company for illegal promotion of a drug was settled against Pfizer and its subsidiary Pharmacia & Upjohn Co. The $2.3 billion fine sanctioned the pharmaceutical company for promoting its painkiller Bextra for off-label uses. Similar charges concerning the drugs Zyvox, Geodon, and Lyrica were also made, along with allegations that the company provided kickbacks to healthcare professionals for prescribing these ...

Register for Complete Access (Valid Email Required)

By registering on MeetingsNet now, you'll not only gain access to Pfizer Settlement May Have CME Implications, you'll get exclusive access to a large archive of premium content.

Already registered? here.